Open Source Imaging Consortium (OSIC)

OSIC – a global, 501(c)(3), not-for-profit cooperative effort between academia, industry and patient advocacy groups – was created to enable rapid, open source advances in the fight against idiopathic pulmonary fibrosis (IPF), fibrosing interstitial lung diseases (ILDs), and other respiratory diseases, including emphysematous conditions.

Our Mission

​OSIC brings together radiologists, clinicians, computational scientists, and industry competitors from around the world to advance digital imaging biomarkers for accurate imaging-based diagnosis, prognosis and prediction of response to therapy.

​The partners work in pre-competitive areas for mutual benefit and, most importantly, the benefit of patients.  

Tweets by OSICild

On its way to becoming the largest and most diverse ILD database in the world

​2022 GOAL
15,000 anonymized scans with accompanying clinical data

COMMITTED ​TO DATE
​16,342 anonymized scans with accompanying clinical data

Learn more

Predicting lung function decline

The OSIC Pulmonary Fibrosis Progression challenged the world’s brightest data science minds to predict lung function decline by using AI machine learning.

Learn more

Driven by Leading Subject-matter Experts

The OSIC Core Science Leadership Team has partnered with a diverse team of experts to tackle the challenges of IPF, ILDs, and the technology needed to make progress.

Institutional Partners

​These organizations have made multi-year commitments of funding and/or pledged to contribute with imaging and clinical data or with other means to OSIC to ensure that it is positioned for success.